Latest Breaking News On - ப்ரிந்ஸ்டந் மேற்கு கண்டுபிடிப்பு வளாகம் - Page 1 : comparemela.com
BeiGene Announces Plans To Build New Manufacturing Facility In New Jersey, 2023 Opening
pharmaceuticalonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmaceuticalonline.com Daily Mail and Mail on Sunday newspapers.
Newmark arranges $76M life science acquisition loan
rew-online.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from rew-online.com Daily Mail and Mail on Sunday newspapers.
Building the Pipeline: Passage Bio Launches Manufacturing Operations
Passage Bio President and CEO Bruce Goldsmith, PhD, details the company’s approach to manufacturing and its progress in developing its pipeline of gene therapies
December 23, 2020
Passage Bio plans to support lab operations for its gene therapy programs at a new lab at the Princeton West Innovation Campus. The lab will be the company’s second manufacturing facility, following the opening of a facility in Harmans, MD, at the campus of Catalent Cell & Gene Therapy.
Share
Gene therapy developers have been ringing out 2020 with a series of announcements about new manufacturing facilities, or at least production agreements with CDMOs. Thermo Fisher will build at its campus in Carlsbad, CA, while Taysha Gene Therapies disclosed plans in Durham, NC. Also, Passage Bio has announced two manufacturing developments at Catalent Cell & Gene Therapy’s Harmans/BWI campus in Harmans, MD and at the Princeton West Innova
Passage Bio signs lease deal for lab space at the Princeton West Innovation Campus
bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.
Published: Dec 16, 2020
PHILADELPHIA, Dec. 16, 2020 (GLOBE NEWSWIRE) Passage Bio, Inc. (Nasdaq: PASG), a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system (CNS) disorders, today announced that it has entered into a long-term lease to support Chemistry, Manufacturing and Controls (CMC) laboratory operations for the company’s gene therapy programs. The new laboratory, slated to open in the second quarter of 2021 at the Princeton West Innovation Campus in Hopewell, New Jersey, will initially focus on state-of-the-art analytical capabilities, clinical assay development and validation, biomarker assay validation and clinical product testing to support both viral vector manufacturing and clinical development.